Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest announcement is out from Allarity Therapeutics, Inc. ( (ALLR) ).
Stockholders of Allarity Therapeutics, Inc. approved several key amendments at their 2024 Annual Meeting, including an increase in authorized shares for the company’s 2021 Equity Incentive Plan from 2,168,330 to 10,594,876, a reduction in the total number of authorized shares from 750,500,000 to 250,500,000, and the potential for a reverse stock split at a ratio to be decided by the board. Additionally, amendments were passed to limit liability for certain officers and to ratify the appointment of an independent auditor, all of which reflect significant corporate governance and structural changes for the company.
For an in-depth examination of ALLR stock, go to TipRanks’ Stock Analysis page.
